Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege
Breast cancers have been shown to elicit tumor-specific immune responses. As in other types of cancer, the antitumor immune response fails to contain breast tumor growth, and a reduction in both the quantity and cytotoxic effectiveness of tumor-infiltrating lymphocytes (TILs) is associated with a po...
保存先:
| 出版年: | Clin Diagn Lab Immunol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1999
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC95708/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10391843/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.6.4.457-463.1999 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|